The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ONCSM FINANCIAL STATEMENTS

Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi — balance sheet, income statement and cash flow trends

ONCSMOncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi

🇹🇷 Turkey · IS · Healthcare · Medical Devices

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0500 M20192020202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue860.8 M ₺Gross Profit484.4 M ₺ · 56%Operating Income261.8 M ₺ · 30%Pre-tax Income136.8 M ₺ · 16%Net Income to Owners79.6 M ₺ · 9%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue860.8 M ₺+18.2%
Gross Profit484.4 M ₺+85.3%
Operating Income261.8 M ₺+318.9%
EBITDA334.9 M ₺+144.7%
Net Income to Owners79.6 M ₺+1,256.1%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M20192020202120222023202420252026

Capital Structure

Q2 2026
Total Assets911.5 M
  • Equity505 M ₺55%
  • Current Liabilities262.2 M ₺29%
  • Long-term Liabilities144.3 M ₺16%

Key Figures

YoY change
Total Assets911.5 M ₺+93.0%
Total Liabilities406.5 M ₺+176.1%
Total Equity505 M ₺+55.3%
Cash & ST Investments30.1 M ₺-42.9%
Total Debt178 M ₺+157.0%
Net Debt148 M ₺+794.7%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M0100 M20192020202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
050 M100 M110.6 M ₺Operating-117.4 M ₺Investing-20.4 M ₺Financing-27.2 M ₺Net Change

Key Figures

YoY change
Operating Cash Flow110.6 M ₺-7.7%
Capital Expenditures-93.9 M ₺—
Free Cash Flow-6.8 M ₺-108.3%
Dividends Paid0 ₺—

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ONCSM

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.